Drug Resistance Program Center for Cancer Research National Cancer Institute P.O. Box B,
Building 535 Frederick, MD 21702-1201 Phone: 301-846-6796 Fax: 301-846-6777
Dr. Mary Kearney received her Ph.D. in Biology at Catholic University in 2007 under the direction of Drs. John Coffin, Sarah Palmer, and Venigalla Rao. She joined the HIV Drug Resistance Program in 2001 as a Biologist in the Virology Core and in 2008 she was promoted to Manager of the Virology Core, now called the Translational Research Unit (TRU). In her current position as Head of the TRU, Dr. Kearney oversees a team that investigates HIV population diversity in vivo, mechanisms for the emergence of drug resistance mutations, and sources of persistent viremia during antiretroviral therapy.